UNIVERSITY OF SOUTHERN CALIFORNIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1880-01-01

Employees: 10K

Market Cap: -

Website: http://startusc.com

Clinical Trials

Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer

Phase 2

Completed

Conditions: Recurrent Cervical Cancer
Stage IIIA Cervical Cancer
Stage IIIB Cervical Cancer
Stage IVA Cervical Cancer
Stage IVB Cervical Cancer

Interventions: Drug: eribulin mesylate

First Posted Date: 2012-08-31

Last Posted Date: 2021-11-15

Lead Sponsor: University of Southern California

Target Recruit Count: 32

Registration Number: NCT01676818

Locations: 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States

Text Message Appointment Reminders

Not Applicable

Completed

Conditions: Emergencies
Text Messages

Interventions: Other: Text message appointment reminder

First Posted Date: 2012-08-30

Last Posted Date: 2015-05-27

Lead Sponsor: University of Southern California

Target Recruit Count: 374

Registration Number: NCT01676337

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception

Not Applicable

Completed

Conditions: Pregnancy
HIV
AIDS

Interventions: Drug: Norethindrone acetate

First Posted Date: 2012-08-17

Last Posted Date: 2015-08-20

Lead Sponsor: University of Southern California

Target Recruit Count: 35

Registration Number: NCT01667978

Locations: 🇺🇸
Los Angeles County Hospital University of Southern California (LAC USC), Los Angeles, California, United States
🇺🇸
Los Angeles County University of Southern California, Los Angeles, California, United States

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

Phase 1

Terminated

Conditions: Breast Cancer
Nausea
Vomiting

Interventions: Drug: granisetron transdermal system
Drug: fosaprepitant dimeglumine
Other: laboratory biomarker analysis

First Posted Date: 2012-07-25

Last Posted Date: 2017-11-17

Lead Sponsor: University of Southern California

Target Recruit Count: 29

Registration Number: NCT01649258

Locations: 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States

Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors

Phase 1

Terminated

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Other: laboratory biomarker analysis
Other: pharmacological study
Biological: recombinant albumin fusion protein sEphB4-HSA

First Posted Date: 2012-07-17

Last Posted Date: 2022-08-24

Lead Sponsor: University of Southern California

Target Recruit Count: 102

Registration Number: NCT01642342

Locations: 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

Phase 2

Withdrawn

Conditions: Anterior Urethral Cancer
Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
Posterior Urethral Cancer
Recurrent Bladder Cancer
Recurrent Urethral Cancer
Regional Transitional Cell Cancer of the Renal Pelvis and Ureter
Stage III Bladder Cancer
Transitional Cell Carcinoma of the Bladder
Ureter Cancer
Urethral Cancer Associated With Invasive Bladder Cancer

Interventions: Drug: cisplatin
Drug: gemcitabine hydrochloride
Drug: methotrexate
Other: laboratory biomarker analysis
Drug: vinblastine
Drug: doxorubicin hydrochloride
Biological: pegfilgrastim

First Posted Date: 2012-07-12

Last Posted Date: 2014-01-29

Lead Sponsor: University of Southern California

Registration Number: NCT01639521

Effects of Whole Body Vibration Exercise on Metabolic Systems in Latino Boys

Not Applicable

Completed

Conditions: Effects of Whole Body Vibration Exercise on Metabolic Systems

Interventions: Other: Exercise intervention

First Posted Date: 2012-07-09

Last Posted Date: 2012-07-09

Lead Sponsor: University of Southern California

Target Recruit Count: 20

Registration Number: NCT01635673

Locations: 🇺🇸
USC Biokinesiology and Physical Therapy, Clinical Exercise Research Center, Los Angeles, California, United States

Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma

Not Applicable

Completed

Conditions: HIV

Interventions: Drug: Etravirine pharmacokinetics in breast milk and plasma

First Posted Date: 2012-06-21

Last Posted Date: 2014-08-13

Lead Sponsor: University of Southern California

Target Recruit Count: 9

Registration Number: NCT01625169

Locations: 🇺🇸
LAC+USC MCA Clinic, Los Angeles, California, United States

Effects of Kuvan on Melatonin Secretion

Phase 4

Completed

Conditions: Phenylketonuria (PKU)

Interventions: Drug: Kuvan
Dietary Supplement: Large Neutral Amino Acid Therapy

First Posted Date: 2012-06-12

Last Posted Date: 2016-11-18

Lead Sponsor: University of Southern California

Target Recruit Count: 10

Registration Number: NCT01617070

Locations: 🇺🇸
Keck School of Medicine, Clinical Trials Unit at Keck Medical Center of USC, Los Angeles, California, United States

Lubricant Versus Lidocaine Gel for Pain Control During Urodynamics

Not Applicable

Completed

Conditions: Pelvic Floor Disorders

Interventions: Drug: Water based lubricant
Drug: 2% lidocaine gel

First Posted Date: 2012-06-05

Last Posted Date: 2015-01-19

Lead Sponsor: University of Southern California

Target Recruit Count: 90

Registration Number: NCT01612156

Locations: 🇺🇸
LAC USC Womens clinic, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy